Navigation Links
Dr. Richard Feinman to speak on the science of diabetes and diet on Oct. 2
Date:9/28/2009

Richard Feinman, PhD, professor of biochemistry and of family medicine at SUNY Downstate Medical Center in Brooklyn, New York, will speak at the annual conference of the European Association for the Study of Diabetes (EASD) on October 2, 2009. EASD is holding its annual conference September 28 October 2 in Vienna, Austria.

Dr. Feinman will be one of four speakers covering the topic, Controversies in Dietary Strategies in the Treatment of Diabetes.

According to Dr. Feinman, it has been scientifically documented that carbohydrate consumption raises blood glucose and there is no disagreement that diabetes is a disease of carbohydrate intolerance. "There really is no controversy about the science," Dr. Feinman explains. "It's as simple as this: An increase in dietary carbohydrate will raise HbA1c, which in turn will raise the risk of microvascular complications, and this is science we all agree on."

"That being said," he adds, "the controversy may indeed be whether or not we are getting good advice from our healthcare professionals, but that is out of my area I will be at the conference in Vienna to explain the science."

Dr. Feinman's presentation will take place at the Messe Wien in van Swieten Hall on October 2, 2009.


'/>"/>

Contact: Richard Feinman
Richard.Feinman@downstate.edu
718-270-2252
SUNY Downstate Medical Center
Source:Eurekalert

Page: 1

Related biology news :

1. Aware, Inc. Announces Richard Moberg to Return as CFO
2. PNNLs Richard Smith named to prestigious Scientific American 50 list of outstanding leaders
3. AGU Journalism Awards won by Margaret Munro and Dr. Richard Smith
4. Brupbacher prize to Nubia Munoz and Sir Richard Peto
5. Jonathan Berg, M.D., Ph.D. awarded Richard King Trainee Award for Best in Genetics in Medicine
6. American Society for Microbiology honors Richard W. Castenholz
7. Office of the Director of National Intelligence, CIO to Speak at Government Security Conference
8. Director of National Intelligence to Speak at Conference
9. Office of the Director of National Intelligence, CIO to Speak at Government Security Conference
10. Director of National Intelligence to Speak at Conference
11. Computer learns dogspeak
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/3/2017)... 3, 2017 A new independent identity strategy ... LLP (IdSP) . Designed to fill a critical niche ... market, founding partners Mark Crego and ... just in identity expertise that span federal governments, the ... The Crego-Kephart combined expertise has a common theme born ...
(Date:2/2/2017)... -- EyeLock LLC, a market leader of iris-based identity authentication ... You Should Know About Biometrics in the Cloud ."  ... a growing concern. In traditional schemes, cryptography is used ... schemes such as username/password suffer from inherent weaknesses. ... elegant solution to the problem of high-security user authentication. ...
(Date:2/1/2017)... IDTechEx Research, a leading provider of independent market research, business ... new report, Sensors for Robotics: Technologies, Markets and Forecasts 2017-2027 ... ... Revenues of ... for Robotics: Technologies, Markets and Forecasts 2017-2027: Machine vision, force sensing ...
Breaking Biology News(10 mins):
(Date:2/16/2017)... 2017  ArmaGen, Inc., a privately held biotechnology ... severe neurological disorders, today reported preliminary evidence of ... company,s investigational therapy for the treatment of Hurler ... I, or MPS I). The initial results from ... today at the 13 th annual WORLD ...
(Date:2/16/2017)... -- UCHealth ( Aurora, Colorado ) becomes ... patient management. In addition to optimizing care coordination for ... lung, UCHealth looks to improve provider workflow by decreasing ... Stephanie Brown, RN , Thoracic Nurse Navigator, says, ... Excel spreadsheet, which was extremely arduous and susceptible to ...
(Date:2/16/2017)...  Rhythm, a biopharmaceutical company developing peptide ... in life-threatening metabolic disorders, today announced the ... of financing with existing investors including Deerfield ... Associates, Pfizer Venture Investments, Third Rock Ventures, ... Rhythm will use the proceeds to advance ...
(Date:2/15/2017)... , 15. Februar 2017  Trianni, Inc. („TRIANNI") ... Inc. (Janssen) eine Lizenzvereinbarung über die Verwendung der ... führenden Plattform für die Entdeckung monoklonaler Antikörper. ... neuartiges chimäres Gensegmentdesign aus, das Janssen den ... Antikörpern bietet und das für die schelle Isolierung ...
Breaking Biology Technology: